Cannabis patents in Thailand
A 2019 order made a commercial cannabis invention unpatentable in Thailand. Two clauses ended when medical research was legalised. The rest of the order did not.
Commercial cannabis inventions
NCPO Order 1/2562, in force 28 January 2019, says an invention containing cannabis, a natural cannabis extract, a substance of the same chemical structure, or a salt, ester, or ether of it, is unpatentable under the Patent Act, section 9(5), if it is to be used commercially. After the section 28 advertisement, if no one requests examination, the Director-General of the Department of Intellectual Property may reject the application or require the claims to be cut. Patent rights that do exist remain subject to every other law that controls production, use, sale, import, export, or possession. [1]
What ended when medical research opened
Clauses 1 and 2 are cancelled from the day the narcotics law is amended to allow medical research. Narcotics Act (No. 7), in force 19 February 2019, is that day. Pending examinations continued under those clauses until they were finished. Clause 5 rewrites Patent Act section 30 generally. It is not a cannabis clause, and it was not cancelled. [1] [2]